Built for biotech commercial, clinical, and medical affairs teams
The CRM that gets biotech runs on KOLs, payers, and trial sites, not deals.
Biotech commercialization and medical affairs run on relationships with key opinion leaders, trial site investigators, payer medical directors, and specialty pharmacy partners. Strkr ships a CRM shaped around biotech work with KOL mapping, trial site coordination, payer tracking, and AI drafting that respects compliance boundaries.
Biotech commercial and clinical work does not fit a sales pipeline. The revenue motion for a specialty therapeutic depends on KOL education, payer coverage decisions, specialty pharmacy fulfillment, and prescriber adoption. Each has its own cadence, compliance posture, and relationship ownership. The pain points below are what Strkr onboarding hears from biotech commercial leaders, medical affairs teams, and clinical operations groups.
KOLs are not accounts
The thought leader map does not fit a contact object.
Biotech commercial depends on KOL relationships at academic medical centers, specialty societies, patient advocacy groups, and major community practices. A KOL has a research portfolio, speaking history, publication count, trial involvement, advisory board membership, and influence tier. Strkr ships a KOL object with influence scoring, research domain tagging, past interaction history, and compliance-sensitive activity logging under Open Payments and Sunshine Act rules.
Trial site coordination is a workflow
A phase 3 trial runs across 180 sites with 40 CRAs.
A pivotal phase 3 trial often runs across 120 to 280 sites with 20 to 60 clinical research associates visiting on 6 to 12-week monitoring cycles. Site activation, enrollment pacing, protocol deviation tracking, and site communication live across a mix of CTMS, EDC, and shared drives. Strkr ships a Trial Site object with activation status, enrollment pacing, CRA assignment, and protocol deviation log alongside the commercial contact view.
Payer coverage is political
The medical director relationship that determines access.
A specialty therapeutic launch succeeds or fails on payer coverage decisions. The commercial team needs to track payer medical director relationships, policy review cycles, prior authorization requirements, and formulary tier placement across 48 state Medicaid programs and 240 commercial payers. Strkr ships a Payer object with medical director contact, policy review date, PA requirement detail, and formulary tier status by product.
Medical affairs activity is compliance-sensitive
The MSL field note that cannot leak to commercial.
Medical science liaisons run scientific exchange with KOLs under firewall rules that keep medical content separate from commercial outreach. An MSL field note cannot be visible to the sales rep. Strkr ships the role model with field-level visibility separation so medical content stays visible to medical affairs and commercial content stays visible to commercial. The audit log captures every cross-role query for compliance review.
Specialty pharmacy coordination
The prescription that routes through SP channel.
A specialty therapeutic typically fills through a limited specialty pharmacy channel (3 to 8 SPs for a typical launch). The commercial team coordinates prescription routing, benefit investigation status, patient assistance program eligibility, and shipment timing across the SP network. Strkr ships a Specialty Pharmacy integration surface and a Prescription Journey object tracking patient-level status through the SP channel.
Patient advocacy groups shape the market
The disease-state community that drives awareness.
A rare disease or specialty therapeutic launch depends on patient advocacy groups for disease awareness, patient education, and payer advocacy. The commercial team manages advocacy group relationships, grant funding, sponsorship, and co-marketing programs. Strkr ships an Advocacy Group object with relationship history, program sponsorships, grant tracking, and co-marketing activity.
The biotech commercial schema
Objects shaped like biotech work.
The default CRM schema does not reflect biotech commercial or medical affairs work. Strkr ships a tunable schema with KOL, HCP, Account (institution), Trial Site, Payer, Specialty Pharmacy, Prescription Journey, and Advocacy Group as first-class objects. The commercial lead can rename or extend anything.
KOL object
Influence tier, domain, publication, advisory.
A KOL in Strkr carries influence tier (tier 1, 2, 3 by domain), research domain tags, publication count, speaking history, trial involvement, advisory board membership, and institutional affiliations. The influence scoring runs across citations, trial roles, and specialty society positions. Compliance-sensitive interactions log under Open Payments and Sunshine Act taxonomy.
HCP object
Prescribing authority, specialty, affiliations.
A healthcare professional in Strkr carries NPI, DEA, specialty, prescribing authority, institutional affiliations, formulary access status, and prescribing history (where available from claims data integrations). The HCP ties to one or more Accounts (institutions) and may hold a KOL role separately.
Account object
Institution, IDN parent, formulary status.
An Account in Strkr represents an institution (hospital, clinic, physician group) with its IDN parent, formulary status by product, pathway inclusion status, and site-of-care posture. The schema distinguishes institution from IDN parent, which matters for formulary decisions that happen at the IDN level.
Trial site object
Activation, enrollment, CRA, deviations.
A Trial Site captures site activation status, enrollment pacing against target, assigned CRA, monitoring visit cadence, protocol deviation log, and site contact roster. For running trials the schema integrates with the CTMS feed through the webhook spec to pull activation events and enrollment counts.
Payer object
Medical director, policy, formulary, PA.
A Payer captures payer name, plan type (commercial, Medicaid, Medicare, exchange), medical director contact, policy review cycle, formulary tier status by product, prior authorization requirement detail, and claims submission detail. The payer object drives the payer coverage pipeline for the commercial team.
Specialty pharmacy object
Channel partner, status, fulfillment.
A Specialty Pharmacy captures SP identity, channel role (hub, dispensing, patient assistance), fulfillment status, patient support service scope, and performance metrics (fill rate, time to therapy, adherence). The SP ties into the Prescription Journey workflow for patient-level tracking.
Prescription journey object
Rx receipt, BI, PA, fill, continuation.
A Prescription Journey tracks the patient-level status from Rx receipt through benefit investigation, prior authorization, patient assistance evaluation, first fill, continuation fills, and discontinuation events. The journey rolls up to time-to-therapy and adherence metrics for the commercial team.
How Strkr AI drafts for biotech work
The AI jobs that fit commercial and medical affairs.
Biotech communication is clinically grounded, compliance-sensitive, and audience-tuned. Strkr AI drafts in the voice the KOL manager or MSL would use with retrieval scope strictly scoped to the KOL record or the medical content library and the compliance boundary enforced.
KOL engagement recap
The post-interaction summary.
After an interaction with a KOL (advisory board, consulting session, speaker engagement, scientific exchange) Strkr AI drafts the recap note with the interaction summary, scientific topics covered, next-step actions, and compliance taxonomy. The commercial lead or MSL reviews and files. The recap sits in the KOL record for the next team member.
Payer policy summary
The policy change digest for the field.
When a payer updates coverage policy Strkr AI drafts the policy change digest for the field reimbursement team with the policy update summary, impact on current prescribers, next-action detail, and talking points for payer outreach. The field team gets the digest same-day instead of a week later.
MSL field note
The scientific exchange record.
An MSL drafts a field note after each KOL scientific exchange. Strkr AI drafts the field note from the MSL's call recording or dictated summary with the scientific topics covered, KOL feedback, publications discussed, and follow-up items. The medical affairs lead reviews. The note lives in the medical-affairs-only visibility scope.
Trial site communication
The site update from clin ops.
For running trials Strkr AI drafts the site update email summarizing recent protocol updates, enrollment pacing, upcoming monitoring visits, and open action items from the last CRA visit. The clin ops lead approves and sends. Site communication cadence lifts because drafting cost drops.
Patient advocacy outreach
The quarterly check-in with the advocacy group.
Strkr AI drafts the quarterly advocacy group check-in with the recent program activity, upcoming grant cycle, co-marketing opportunities, and disease-state education assets. The patient advocacy lead reviews and sends. The relationship stays warm with specific context instead of a generic touchpoint.
Specialty pharmacy performance review
The monthly scorecard narrative.
Strkr AI drafts the monthly specialty pharmacy performance review summarizing fill rate, time to therapy, adherence rate, and patient satisfaction scores with variance versus the prior month and the launch benchmark. The channel manager reviews and sends to the SP partner. The scorecard conversation stays data grounded.
The biotech cockpit
The view the commercial lead opens before the Monday leadership meeting.
Biotech commercial leaders run on weekly rituals pulled from a mix of IQVIA data, CTMS exports, payer intelligence, and field activity. Strkr ships a biotech cockpit that pulls KOL activity, trial site progress, payer coverage status, and prescription journey into a single view.
KOL engagement heatmap
Interaction volume by influence tier.
The KOL heatmap shows interaction volume by tier (tier 1, 2, 3) with the past-30-day activity and the four-week trend. Tier 1 KOLs with no interaction in 90 days flag for an outreach. The commercial lead sees the gaps and deploys the field appropriately.
Trial site enrollment
Pacing versus target by site.
The trial site section shows every active site with enrollment pacing versus target, next monitoring visit, and open deviation count. The clinical operations lead sees the 11 sites behind pace that need an intervention this quarter.
Payer coverage status
Formulary tier status across top payers.
The payer coverage view shows formulary tier status across the top 40 payers covering about 80 percent of the commercial lives. Payers in policy review flag with the review date and the current status. The market access team sees the next three policy reviews that need focused attention.
Prescription journey
Time-to-therapy and adherence trend.
The prescription journey section shows time-to-therapy (Rx to first fill) and 12-week adherence across the SP network. A 32-day time-to-therapy on a therapeutic with a 14-day target triggers an SP channel conversation and a hub operations review.
Field activity
Rep touches versus plan.
The field activity section shows field rep touches versus the territory plan with coverage gaps. A rep who covers 60 percent of their target call plan surfaces for the regional manager one-on-one. The view is role-filtered so medical affairs sees MSL activity separately from commercial activity.
Medical affairs activity
MSL field notes and scientific exchange.
The medical affairs section (visible to medical affairs role only) shows MSL field notes, scientific exchange activity by KOL, and advisory board activity. The medical affairs lead uses the view to balance MSL coverage across KOLs and ensure scientific exchange cadence.
Head-to-head
Strkr vs Veeva CRM or a generic sales CRM for biotech.
The comparison below is Strkr's biotech posture versus a typical life-sciences CRM applied to a specialty therapeutic launch.
Feature
Strkr
Life-sciences CRM typical posture
KOL object with influence scoring
First-class with research domain and publication.
Contact with manual tagging.
Open Payments / Sunshine Act taxonomy
Interaction logging with compliance taxonomy.
Partial, manual.
Trial site coordination
With CTMS webhook feed.
Separate system.
Payer coverage pipeline
Policy, formulary tier, PA requirement.
Manual tracking.
Specialty pharmacy integration
Hub and dispensing SP via webhooks.
Manual CSV.
Prescription journey tracking
Patient-level with SP data.
Aggregate IQVIA only.
MSL and commercial firewall
Field-level visibility separation.
Separate instance typical.
HIPAA with BAA
Available on request.
Available but enterprise-tier.
Pricing
Flat per seat.
Six-figure annual contracts typical.
How teams use Strkr
Five biotech playbooks.
The playbooks below are patterns Strkr onboarding sees across biotech deployments.
Pattern A
The 24-person commercial team at a pre-launch rare disease biotech.
A pre-launch rare disease biotech with 24 commercial team members (18 field reps, 4 MSLs, 2 payer leads) needed CRM infrastructure for KOL mapping, payer tracking, and field activity logging. The team was coming off Veeva at a prior company and wanted the same capability without the six-figure annual contract. Strkr onboarding ran a 24-business-day migration configuring the biotech schema with the role-based visibility separation. Launch readiness was achieved on time with CRM instrumentation across every commercial function.
Pattern B
The 120-site phase 3 trial coordination.
A biotech running a 120-site phase 3 pivotal trial needed to coordinate site activation, enrollment pacing, CRA assignments, and sponsor-to-site communication alongside the commercial team's early KOL engagement. Strkr onboarding configured the Trial Site object with Medidata CTMS integration through the webhook spec. The clinical operations team and the commercial team shared the KOL record while the trial-site data stayed scoped to clin ops. Enrollment pacing improved 18 percent after the shared KOL visibility surfaced over-worked site PIs.
Pattern C
The specialty therapeutic launch with 6 SP partners.
A specialty therapeutic launch channeled through 6 specialty pharmacy partners (one hub, 5 dispensing SPs). The channel manager needed patient-level visibility across the SP network for time-to-therapy and adherence tracking. Strkr onboarding configured the Prescription Journey object with SP integrations through the webhook spec and HIPAA BAA scope. Time-to-therapy dropped from 38 days at month three to 14 days at month twelve as the SP partners improved on the shared scorecard.
Pattern D
The 42-member medical affairs team.
A commercial-stage biotech with a 42-member medical affairs team (28 MSLs, 8 medical directors, 6 publication leads) needed a CRM scoped to medical content with firewall separation from commercial. Strkr onboarding configured the role model so medical affairs saw KOL scientific exchange records while commercial saw promotional activity only. The audit log captured cross-role queries for compliance review. The firewall held clean in a subsequent compliance audit.
Pattern E
The patient advocacy program at an immuno-oncology biotech.
An immuno-oncology biotech ran patient advocacy programs across 11 disease-state advocacy groups with annual grant cycles totaling about $4.2 million. The patient advocacy lead needed program tracking, grant workflow, and co-marketing coordination. Strkr onboarding configured the Advocacy Group object with grant workflow and co-marketing activity logging. Grant cycle compliance improved and the advocacy program ran with full documentation for finance and compliance review.
Run the biotech on a CRM shaped for the commercial and medical motion.
Book a 30 minute call. We will walk through the biotech schema, the KOL engagement workflow, and the payer coverage pipeline with your actual therapeutic area and team structure.
Does Strkr integrate with Veeva CRM, Medidata CTMS, or IQVIA data feeds?
Strkr integrates with every major life-sciences data platform through its REST and GraphQL API, outbound webhooks with HMAC signing, and the published OpenAPI spec. For Veeva CRM migrations Strkr can run a dual-run pattern that keeps Veeva as the system of record during cutover and migrates fully once the team is comfortable. For Medidata CTMS the integration pulls site activation and enrollment events on a webhook cadence. For IQVIA Rx data the integration pulls prescriber-level data on the monthly feed cadence. The integrations land in two to four engineering sprints depending on complexity.
How does Strkr handle Open Payments and Sunshine Act compliance?
Interactions with HCPs that involve transfer of value (meals, consulting fees, speaker fees, advisory board honoraria, travel reimbursement) log with the Open Payments taxonomy (nature of payment, dollar amount, context) and feed the annual Open Payments report submission. The audit log captures every TOV event with timestamp, user, and recipient for compliance review. For biotechs running their own aggregate spend platform Strkr integrates through the webhook spec with HMAC signing. The compliance team sees the full TOV picture across the commercial team.
Can Strkr maintain the firewall between medical affairs and commercial?
Yes. The role model supports field-level visibility separation so medical content (MSL field notes, scientific exchange records, publication strategy) stays visible to medical affairs while commercial content (field rep touches, payer coverage, promotional activity) stays visible to commercial. The KOL record is shared with role-filtered sections. The audit log captures every cross-role query for compliance review. For organizations that require full separate instances (strictest compliance posture) Strkr supports separate tenants with controlled data sharing through the webhook spec.
How does Strkr handle HIPAA for patient-level data in the prescription journey?
Strkr is HIPAA compliant with a BAA available on request (no tier gate). Patient-level data in the Prescription Journey (patient identifiers, diagnosis, medication, SP touchpoints) runs under the BAA scope. The AI calls run with retrieval scope strictly scoped to the SP channel data with PHI handling consistent with HIPAA minimum necessary. Integration tokens with the SP partners live in AWS KMS. The audit log captures every patient-level record access for compliance review.
What does Strkr cost compared to Veeva CRM, IQVIA Technology, or Pharmacyclics-style custom builds?
Strkr prices flat per seat at $29 Starter, $59 Pro, and $119 Scale per user per month with a 14-day trial. For a 60-person commercial team on Scale the monthly spend runs $7,140 for seats plus $49 for AI Enhancement. Veeva CRM typically runs six-figure to seven-figure annual contracts for mid-size biotech launches with per-user monthly pricing in the $150 to $250 range plus implementation services. IQVIA Technology and Pharmacyclics-style custom builds run even higher. Strkr sits dramatically lower on seat price while adding the AI drafting and the modern API posture.
Can Strkr handle a biotech running multiple therapeutic programs on one platform?
Yes. The admin configures therapeutic areas (oncology, immunology, rare disease, neurology) with therapeutic-area-specific KOL mapping, payer coverage pipelines, trial site coordination, and field activity. A commercial team member working across therapeutic areas sees separate pipelines for each with cross-therapeutic-area reporting rolling up to the commercial lead. Role-based visibility ensures therapeutic-area firewall where competitive or compliance considerations require it.
What is the full compliance posture for a biotech migration?
Strkr is HIPAA compliant with BAA on request, GDPR and CCPA compliant today, and SOC 2 Type II is in progress with a target of 2026-Q4. Open Payments and Sunshine Act taxonomy is built into the HCP interaction object. The audit log captures every record read, record write, and AI call with 90-day default retention tunable per tenant to the FDA, FTC, and HHS retention ceilings. Integration tokens live in AWS KMS, platform credentials live in AWS Secrets Manager. SSO (SAML and OIDC) is live on Scale tier through Clerk, MFA with TOTP plus text-based verification is live across all tiers, and Verified Domains are live on Scale tier.
No sales call, no migration consultant, no four-month implementation. Enter your card, get 14 days of the full Pro tier, cancel any time before day 14 with zero charge. Spin up a workspace, import your CSV, and have something useful before lunch.
We use cookies.
Essential cookies keep the site working. If you accept, we also enable Google Analytics
so we can see which pages help and which don't. Reject to opt out entirely. Details in our
Privacy Policy.
